SG Americas Securities’s Boston Scientific BSX Stock Holding History

SG Americas Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-44,000	Closed	-$251K	–	2886
2024 Q1	$251K	Hold	44,000	–	–	﹤0.01%	1812
2023 Q4	$59K	Hold	44,000	–	–	﹤0.01%	2894
2023 Q3	$46K	Buy	+44,000	New	+$2.31M	﹤0.01%	2955
2020 Q4	–	Sell	-248,000	Closed	-$45K	–	3339
2020 Q3	$45K	Buy	248,000 +57,500	+30%	+$2.22M	﹤0.01%	2530
2020 Q2	$14K	Buy	190,500 +140,500	+281%	+$5.06M	﹤0.01%	3621
2020 Q1	$2K	Sell	50,000 -30,000	-38%	-$1.17M	﹤0.01%	3394
2019 Q4	$69K	Buy	+80,000	New	+$3.35M	﹤0.01%	3020
2019 Q1	–	Sell	-75,000	Closed	-$88K	–	3369
2018 Q4	$88K	Hold	75,000	–	–	﹤0.01%	2746
2018 Q3	$360K	Hold	75,000	–	–	﹤0.01%	2283
2018 Q2	$131K	Hold	75,000	–	–	﹤0.01%	2899
2018 Q1	$38K	Hold	75,000	–	–	﹤0.01%	3116
2017 Q4	$26K	Buy	+75,000	New	+$2.07M	﹤0.01%	3036
2013 Q4	–	Sell	-200,000	Closed	-$14K	–	2679
2013 Q3	$14K	Buy	+200,000	New	+$2.16M	﹤0.01%	2901

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SG Americas Securities's BSX Position: Q2 2026 in Review

SG Americas Securities increased its Boston Scientific (BSX) stake by 307% in Q2 2026, buying an estimated $155M and bringing the position to 3,785,401 shares worth $162M. The position accounts for 0.09% of the portfolio, ranked #152.

SG Americas Securities first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. 1,484 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

SG Americas Securities held 3,785,401 shares of Boston Scientific worth $162M as of Q2 2026.
SG Americas Securities bought 2,854,246 Boston Scientific shares in Q2 2026, an estimated $155M.
Boston Scientific made up 0.09% of SG Americas Securities's portfolio in Q2 2026, its #152 holding.
SG Americas Securities first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
1,484 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.